NCT00782379 · OUTCOME
Non-relapse Mortality at Day 100 After Peripheral Blood Stem Cell Transplantation (PBSCT)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- Day 100
Analysis population: 2 patients died before Day 100 and therefore are eligible to be evaluated for non-relapse mortality
Groups in this outcome
Haploidentical Transplant
Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant
| Group | Source count |
|---|---|
| Haploidentical Transplant | 2 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Haploidentical Transplant | 2 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 2
- denoms
- counts
- group Id
- OG000
- value
- 2
- units
- Participants
- groups
- description
- Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant
- id
- OG000
- title
- Haploidentical Transplant
- param Type
- NUMBER
- population Description
- 2 patients died before Day 100 and therefore are eligible to be evaluated for non-relapse mortality
- reporting Status
- POSTED
- time Frame
- Day 100
- title
- Non-relapse Mortality at Day 100 After Peripheral Blood Stem Cell Transplantation (PBSCT)
- type
- SECONDARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle